Van Laar, Ryan
Lincoln, Mitchel
Van Laar, Barton
Article History
Received: 22 October 2017
Revised: 1 December 2017
Accepted: 4 December 2017
First Online: 23 January 2018
Change Date: 20 March 2018
Change Type: Update
Change Details: This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
Competing interests
: Geneseq Biosciences is a privately-held start-up company, aiming to develop a novel diagnostic biomarker for melanoma detection and management. A provisional patent application has been filed on the work described herein and we are actively pursuing clinical and technical validation partners locally and nationally.